Simulations Plus Announces Second Quarter Fiscal Year 2025 Earnings and Conference Call Date
Simulations Plus (Nasdaq: SLP), a provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, has scheduled its second quarter fiscal 2025 earnings release and conference call.
The company will announce its Q2 FY2025 financial results after market close on Thursday, April 3, 2025, followed by a management-hosted conference call at 5:00 p.m. Eastern Time. Investors and shareholders can join the webcast through registration or dial in using 1-877-451-6152 (domestic) or 201-389-0879 (international).
Simulations Plus (Nasdaq: SLP), fornitore di cheminformatica, biosimulazione, soluzioni di prestazioni e intelligenza abilitate dalla simulazione, e comunicazioni mediche per l'industria biopharma, ha programmato la sua comunicazione dei risultati finanziari del secondo trimestre dell'anno fiscale 2025 e la relativa conference call.
L'azienda annuncerà i risultati finanziari del Q2 FY2025 dopo la chiusura del mercato il giovedì 3 aprile 2025, seguita da una conference call ospitata dalla direzione alle 17:00 ora orientale. Gli investitori e gli azionisti possono partecipare al webcast tramite registrazione o chiamando il numero 1-877-451-6152 (nazionale) o 201-389-0879 (internazionale).
Simulations Plus (Nasdaq: SLP), proveedor de quimioinformática, biosimulación, soluciones de rendimiento e inteligencia habilitadas para simulación, y comunicaciones médicas para la industria biofarmacéutica, ha programado el lanzamiento de sus resultados financieros del segundo trimestre del año fiscal 2025 y la conferencia telefónica correspondiente.
La empresa anunciará sus resultados financieros del Q2 FY2025 después del cierre del mercado el jueves 3 de abril de 2025, seguido de una conferencia telefónica organizada por la dirección a las 5:00 p.m. hora del Este. Los inversores y accionistas pueden unirse al webcast a través de registro o llamando al 1-877-451-6152 (nacional) o 201-389-0879 (internacional).
Simulations Plus (Nasdaq: SLP), 화학 정보학, 생물 시뮬레이션, 시뮬레이션 기반 성능 및 지능 솔루션, 그리고 생명공학 산업을 위한 의료 커뮤니케이션 제공업체가 2025 회계연도 2분기 실적 발표 및 컨퍼런스 콜 일정을 잡았습니다.
회사는 2025년 4월 3일 목요일 시장 종료 후 2025 회계연도 2분기 재무 결과를 발표하고, 동부 표준시 오후 5시에 경영진이 주최하는 컨퍼런스 콜이 이어질 것입니다. 투자자와 주주들은 등록을 통해 웹캐스트에 참여하거나 1-877-451-6152 (국내) 또는 201-389-0879 (국제)로 전화하여 참여할 수 있습니다.
Simulations Plus (Nasdaq: SLP), fournisseur de chimiométrie, de biosimulation, de solutions de performance et d'intelligence activées par simulation, ainsi que de communications médicales pour l'industrie biopharmaceutique, a programmé la publication de ses résultats financiers du deuxième trimestre de l'exercice 2025 et la conférence téléphonique qui l'accompagne.
L'entreprise annoncera ses résultats financiers du Q2 FY2025 après la fermeture du marché le jeudi 3 avril 2025, suivie d'une conférence téléphonique animée par la direction à 17h00, heure de l'Est. Les investisseurs et actionnaires peuvent rejoindre le webcast par inscription ou composer le 1-877-451-6152 (national) ou le 201-389-0879 (international).
Simulations Plus (Nasdaq: SLP), Anbieter von Cheminformatik, Biosimulation, simulationsgestützten Leistungs- und Intelligenzlösungen sowie medizinischer Kommunikation für die Biopharmaindustrie, hat die Veröffentlichung seiner Finanzergebnisse für das zweite Quartal des Geschäftsjahres 2025 und die dazugehörige Telefonkonferenz geplant.
Das Unternehmen wird seine finanziellen Ergebnisse für das Q2 FY2025 nach Börsenschluss am Donnerstag, den 3. April 2025 bekannt geben, gefolgt von einer von der Geschäftsführung geleiteten Telefonkonferenz um 17:00 Uhr Eastern Time. Investoren und Aktionäre können über eine Registrierung am Webcast teilnehmen oder sich unter 1-877-451-6152 (national) oder 201-389-0879 (international) einwählen.
- None.
- None.
Conference call to be on Thursday, April 3, 2025, at 5 p.m. ET
Management will host a conference call that same day at 5:00 p.m. Eastern Time to discuss the results. Investment professionals and all current and prospective shareholders are invited to join the live webcast by registering here. The conference call can also be accessed by dialing 1-877-451-6152 (domestic) or 201-389-0879 (international) or by clicking on this Call me™ link to request a return call. The webcast can be accessed on the investor relations page of the Simulations Plus website at www.simulations-plus.com/investorscorporate-profile/corporate-profile/ where it will also be available for replay approximately one hour following the call.
About Simulations Plus, Inc.
With more than 25 years of experience serving clients globally, Simulations Plus stands as a premier provider in the biopharma sector, offering advanced software and consulting services that enhance drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. Our comprehensive biosimulation solutions integrate artificial intelligence/machine learning (AI/ML), physiologically based pharmacokinetics, physiologically based biopharmaceutics, quantitative systems pharmacology/toxicology, and population PK/PD modeling approaches. We also deliver simulation-enabled performance and intelligence solutions alongside medical communications support for clinical and commercial drug development. Our cutting-edge technology is licensed and utilized by leading pharmaceutical, biotechnology, and regulatory agencies worldwide. For more information, visit our website at www.simulations-plus.com. Follow us on LinkedIn | X | YouTube.
Environmental, Social, and Governance (ESG)
We focus our Environmental, Social, and Governance (ESG) efforts where we can have the most positive impact. To learn more about our latest initiatives and priorities, please visit our website to read our 2023 ESG update.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250320267438/en/
Financial Profiles
Lisa Fortuna
310-622-8251
slp@finprofiles.com
Source: Simulations Plus, Inc.
FAQ
When will Simulations Plus (SLP) release its Q2 2025 earnings?
How can investors join the Simulations Plus (SLP) Q2 2025 earnings call?
What time is the Simulations Plus (SLP) Q2 2025 earnings conference call?
Where can I find the replay of SLP's Q2 2025 earnings call?
